The importance of reporting suspected adverse reactions caused by new drugs.

M. Antonieta Agusti Escasany

doi:10.1177/1352458515600252

The importance of reporting suspected adverse reactions caused by new drugs.

M. Antonieta Agusti Escasany^*

^*Corresponding author for this work

Department of Pharmacology, Therapeutics and Toxicology

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	1478-1479
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	21
Issue number	11
DOIs	https://doi.org/10.1177/1352458515600252
Publication status	Published - 1 Oct 2015

Keywords

Fingolimod
Teriflunomide

Access to Document

10.1177/1352458515600252

Cite this

@article{67edd2341d1947459745b70f856628c6,

title = "The importance of reporting suspected adverse reactions caused by new drugs.",

keywords = "Fingolimod, Teriflunomide, Fingolimod, Teriflunomide, Fingolimod, Teriflunomide",

author = "{Agusti Escasany}, {M. Antonieta}",

year = "2015",

month = oct,

day = "1",

doi = "10.1177/1352458515600252",

language = "English",

volume = "21",

pages = "1478--1479",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "11",

}

TY - JOUR

T1 - The importance of reporting suspected adverse reactions caused by new drugs.

AU - Agusti Escasany, M. Antonieta

PY - 2015/10/1

Y1 - 2015/10/1

KW - Fingolimod

KW - Teriflunomide

KW - Fingolimod

KW - Teriflunomide

KW - Fingolimod

KW - Teriflunomide

U2 - 10.1177/1352458515600252

DO - 10.1177/1352458515600252

M3 - Article

SN - 1352-4585

VL - 21

SP - 1478

EP - 1479

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 11

ER -